Reorganizing the approach to diabetes through the application of registries

Not Applicable

• Conditions: Type 2 diabetes; Nutritional, Metabolic, Endocrine; Type 2 diabetes mellitus

• Registration Number: ISRCTN14359671
• Lead Sponsor: niversity of Alberta

Brief Summary

2017 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/28166804 2020 qualitative results in https://pubmed.ncbi.nlm.nih.gov/32025300 (added 07/02/2020) 2020 qualitative results in https://pubmed.ncbi.nlm.nih.gov/33941176/ (added 05/05/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-07
• Last Update Posted: 17 May 2021
• Study Completion: 2025-09-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

1. Patients >18 years of age diagnosed with type 2 diabetes
2. Recently (within last 1-2 years) received care from the First Nations health facility
3. Provided verbal consent for First Nations health care workers to manage their diabetes

Exclusion Criteria

1. Patients with type 1 diabetes
2. Patients <18 years of age
3. Those who are subsequently discovered not to have type 2 diabetes (and were not initially in the baseline period)
4. Those refusing care within the First Nations health facility; patients with type 2 diabetes identified after the conclusion of the baseline phase of the project

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. A1c<br> 2. Blood pressure<br> 3. Cholesterol<br> Data collected for regular clinical care is used to assess the primary and secondary outcomes. There is no additional data collected from patients specific to the RADAR study. It may be considered a type of chart review. Timepoints: baseline, end of Intervention (minimum 1 year, depending on the community).<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. The proportion of clinical measures and tasks completed in accordance with Canadian Diabetes Association Clinical Practice guidelines (e.g., A1c, BP, cholesterol, foot and eye examination, receipt of vaccinations, smoking cessation counseling)<br> 2. The number of patients registered in CARE<br> 3. The proportion of patients linked to a health services provider<br> Data collected for regular clinical care is used to assess the primary and secondary outcomes. There is no additional data collected from patients specific to the RADAR study. It may be considered a type of chart review. Timepoints: baseline, end of Intervention (minimum 1 year, depending on the community).<br>